Top Qs
Timeline
Chat
Perspective
Corixa (company)
U.S. biotechnology/pharmaceutical company From Wikipedia, the free encyclopedia
Remove ads
Corixa was a biotechnology/pharmaceutical company based in Seattle, Washington, involved in the development of immunotherapeutics to combat autoimmune diseases, infectious diseases, and cancer. It was founded in 1994. It operated a laboratory and production facility in Hamilton, Montana.
 | This article needs additional citations for verification. (July 2020) |
| This article relies largely or entirely on a single source. (July 2022) |
In 2005, the European pharmaceuticals giant GlaxoSmithKline completed the acquisition of Corixa.[1] GSK had formerly made use of the Corixa's MPL (Monophosphoryl lipid A, a derivative of the lipid A molecule), an adjuvant in some of their vaccines.
Remove ads
External links
- "Corixa Corporation - powering the immune system". Archived from the original on 2006-03-01.
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads